Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biolife Sciences (BLFE)
OTHER OTC:BLFE
Biolife Sciences (BLFE) Stock Price & Analysis
52 Followers
BLFE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume1.00K
Average Volume (3M)N/A
Market Cap
$1.57K
Enterprise Value-$603.42K
Total Cash (Recent Filing)$828.78K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta-116.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,681,815
30 Day Avg. VolumeN/A
Standard Deviation19.25
R-Squared0.03
Alpha1.86
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biolife Sciences News
BLFE FAQ
What was Biolife Sciences’s price range in the past 12 months?
Currently, no data Available
What is Biolife Sciences’s market cap?
Currently, no data Available
When is Biolife Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biolife Sciences’s earnings last quarter?
Currently, no data Available
Is Biolife Sciences overvalued?
According to Wall Street analysts Biolife Sciences’s price is currently Overvalued.
Does Biolife Sciences pay dividends?
Biolife Sciences does not currently pay dividends.
What is Biolife Sciences’s EPS estimate?
Biolife Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolife Sciences have?
Biolife Sciences has 1,566,831,800 shares outstanding.
What happened to Biolife Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biolife Sciences?
Currently, no hedge funds are holding shares in BLFE
---
Company Description
Biolife Sciences
Rhino Novi, Inc. engages in the development of mobile applications and Voice over Internet Protocol (VoIP) services. It offers virtual calling call products and social VoIP. The company was founded on March 31, 2000 and is headquartered in Henderson, NV.
---
Leap Therapeutics
―
Adverum Biotechnologies
―
Abeona Therapeutics
―
Voyager Therapeutics
―
---